HOME >> BIOLOGY >> NEWS
Tastier tomatoes in the future?

Tomatoes are good for you. They strengthen the immune system and can prevent heart and circulatory disease. Now, researchers from the Max Planck Institute of Molecular Plant Physiology, in co-operation with Israeli scientists, have identified DNA fragments in tomatoes that make their contents both healthy and tasty. The researchers crossed wild tomatoes with cultured ones, then investigated the contents and genetic make-up of the hybrid. The results could allow tomato growers to use wild tomatoes to produce cultured tomatoes with the characteristics they desire (Nature Biotechnology, March 12, 2006).

Tomatoes are a major nutrient for humans. In 2004, 120,000 tonnes of tomatoes were harvested worldwide - and every year this number increases. Numerous medical studies have shown the health value of tomatoes. Lycopen, the pigment that makes tomatoes red, can for example prevent heart disease. Tomatoes furthermore contain a lot of vitamins C and E, indispensable for human nourishment. But after centuries of cultivation for shape, colour, and other useful qualities, our cultured tomatoes today are of small genetic diversity, in comparison with wild types. This has affected the taste and health value of the fruits.

To cultivate tomato strains with particular characteristics, researchers have to increase the genetic diversity of cultured tomatoes. This can be done either by cross-breeding them with wild tomatoes, or changing their genetic make-up technologically. Scientists from the Max Planck Institute for Molecular Plant Physiology in Golm, and their Israeli colleagues at Hebrew University in Jerusalem, chose the second option. They investigated strains of tomatoes created from the crossing of cultured and wild types. Their goal was to identify the biochemical composition of fruits and determine which factors control their development. The German-Israeli research team used a method of analysis developed at the Max Planck Institute for Molecular Plant Physi
'"/>

Contact: Dr. Alisdair R. Fernie
fernie@mpimp-golm.mpg.de
49-331-567-8211
Max-Planck-Gesellschaft
24-Mar-2006


Page: 1 2

Related biology news :

1. FDA finds no strong link between tomatoes and reduced cancer risk
2. Scientists genetically engineer tomatoes with enhanced folate content
3. Unique tomatoes tops in disease-fighting antioxidants
4. Anyway you slice it, tomatoes cut through drought with new gene
5. Cellulosic ethanol: Fuel of the future?

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Tastier tomatoes the future

(Date:5/24/2013)... New Orleans, LA After studying noise in one ... or not noise levels exceeded municipal ordinances, Annette Hurley, ... Center New Orleans, and Eric Arriaga, a third-year LSUHSC ... technology to protect their own hearing health. Their case ... Advance for Hearing Practice Management ., "An important ...
(Date:5/23/2013)... fruit, can be made both better-tasting and longer-lasting thanks ... "Working with GM tomatoes that are different to normal ... allows us to pinpoint exactly how to breed in ... Innes Centre. , The research could also lead to ... characteristics because even higher levels of the compounds can ...
(Date:5/23/2013)... By discovering the new mechanism by which estrogen suppresses ... revealed a potential new approach toward treating certain liver ... and colleagues believe they are changing long-held views in ... issue of the journal Science Signaling . , ... years has been that only receptors located in the ...
Breaking Biology News(10 mins):Please do try this at home 2The world's favorite fruit only better-tasting and longer-lasting 2UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2
(Date:5/23/2013)... Colo. , May 23, 2013 Venaxis, ... diagnostic company focused on obtaining FDA clearance and commercializing ... today announced the pricing of an underwritten public offering ... warrants to purchase 3,500,000 shares of its common stock ... a combined public offering price of $1.25 per share ...
(Date:5/23/2013)... , May 23, 2013 PuraMed ... developer, and marketer of over-the-counter (OTC) medicinal and ... research opinion on the company based on low ... , Non-Prescription, All Natural Product to Treat ... Product Outperforms #1 Prescription Competitor , Currently ...
(Date:5/23/2013)... LAGUNA HILLS, Calif. , May 23, 2013 /PRNewswire-USNewswire/ ... CA recently became the first hospital on ... site robotic technology. This new surgical option provides women ... Marc Winter , ... gynecologist and surgeon and medical director of minimally ...
(Date:5/23/2013)... 2013 Northwest Biotherapeutics (NASDAQ: NWBO ... personalized immune therapies for solid tumor cancers, announced ... year,s American Society Of Clinical Oncology (ASCO) meeting in ... role in immune therapy.  (Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO ... the pre-eminent conference focused on clinical treatment of cancer, ...
Breaking Biology Technology:Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3
Cached News: